Tannic acid attenuates hepatic oxidative stress, apoptosis and inflammation by activating the Keap1‑Nrf2/ARE signaling pathway in arsenic trioxide‑toxicated rats
Related Experiment Video
Updated: Dec 7, 2025

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Mengying Li1, Panpan Liu1, Yucong Xue1
1School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China.
Abstract:
The present study was performed to investigate the protective effects of tannic acid (TA) on liver injury induced by arsenic trioxide (ATO) and to elucidate the mechanism involved as related to the Kelch‑like ECH‑associated protein 1 (Keap1)‑nuclear factor erythroid 2‑related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway. Adult rats were intraperitoneally injected with TA, while ATO was administered 1 h later. On the 11th day, the rats were euthanized to determine any liver histological changes, liver function, and the activities of antioxidant, antiapoptosis and proinflammatory cytokines in the liver. Furthermore, the protein expression levels of nuclear Nrf2, total Nrf2, Keap1, Heme oxygenase‑1 (HO‑1), NADPH quinine oxidoreductase‑1 (NQO1), and γ‑glutamylcysteine synthetase (γ‑GCS) were determined using western blot analysis. The results showed that TA treatment ameliorated ATO‑induced liver histological changes and decreased the ATO‑induced increased alanine aminotransferase (ALT) and aspartate transaminase (AST) serum levels. Activities of the antioxidant enzymes significantly were increased, while the levels of malondialdehyde (MDA) and reactive oxygen species (ROS) were attenuated following TA treatment. In addition, TA treatment inhibited ATO‑induced liver apoptosis and inflammatory responses, increased Bcl‑2 protein expression level and reduced the levels of Bax, caspase‑3, interleukin (IL)‑1β, IL‑6 and tumor necrosis factor (TNF)‑α. Furthermore, TA treatment increased the protein expression levels of Nrf2 and Keap1, HO‑1, NQO1 and γ‑GCS. The results demonstrated that TA has a protective effect on ATO‑treated hepatic toxicity and that its underlying mechanism could be due to TA activation of the Keap1‑Nrf2/ARE signaling pathway, to reduce oxidative stress, apoptosis and inflammation in ATO‑intoxicated rats.
Insights
Tannic acid (TA) protects against arsenic trioxide (ATO)-induced liver injury by activating the Keap1-Nrf2/ARE pathway. This reduces oxidative stress, apoptosis, and inflammation, offering a potential therapeutic strategy for arsenic poisoning.
Area of Science:
- Toxicology
- Hepatology
- Molecular Biology
Background:
- Arsenic trioxide (ATO) is a toxic metalloid that can cause significant liver damage.
- Oxidative stress, apoptosis, and inflammation are key mechanisms underlying ATO-induced hepatotoxicity.
- The Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway plays a crucial role in cellular defense against oxidative stress.
Purpose of the Study:
- To investigate the protective effects of tannic acid (TA) against arsenic trioxide (ATO)-induced liver injury in rats.
- To elucidate the underlying molecular mechanisms, particularly focusing on the Keap1-Nrf2/ARE signaling pathway.
Main Methods:
- Rats were treated with TA followed by ATO administration.
- Liver function (ALT, AST), histological changes, oxidative stress markers (ROS, MDA), apoptosis markers (Bcl-2, Bax, caspase-3), and inflammatory cytokines (IL-1β, IL-6, TNF-α) were assessed.
- Western blot analysis was used to determine the protein expression levels of Keap1, Nrf2, HO-1, NQO1, and γ-GCS.
Main Results:
- TA treatment ameliorated ATO-induced liver damage, normalizing ALT and AST levels.
- TA significantly increased antioxidant enzyme activities while reducing oxidative stress markers (ROS, MDA).
- TA inhibited ATO-induced apoptosis and inflammation, evidenced by altered expression of apoptosis-related proteins and cytokines.
- TA treatment upregulated the protein expression of Nrf2, Keap1, HO-1, NQO1, and γ-GCS.
Conclusions:
- Tannic acid exhibits significant hepatoprotective effects against arsenic trioxide toxicity.
- The protective mechanism involves the activation of the Keap1-Nrf2/ARE signaling pathway.
- TA's ability to mitigate oxidative stress, apoptosis, and inflammation makes it a promising agent for treating arsenic-induced liver injury.
